170 related articles for article (PubMed ID: 18201118)
1. Histologic features and prognosis in pediatric medulloblastoma.
Verma S; Tavaré CJ; Gilles FH
Pediatr Dev Pathol; 2008; 11(5):337-43. PubMed ID: 18201118
[TBL] [Abstract][Full Text] [Related]
2. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
[TBL] [Abstract][Full Text] [Related]
3. Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile.
Sadighi Z; Vats T; Khatua S
J Child Neurol; 2012 Oct; 27(10):1302-7. PubMed ID: 22826514
[TBL] [Abstract][Full Text] [Related]
4. Distinctive MRI features of pediatric medulloblastoma subtypes.
Yeom KW; Mobley BC; Lober RM; Andre JB; Partap S; Vogel H; Barnes PD
AJR Am J Roentgenol; 2013 Apr; 200(4):895-903. PubMed ID: 23521467
[TBL] [Abstract][Full Text] [Related]
5. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor Consortium.
Gilles FH; Brown WD; Leviton A; Tavaré CJ; Adelman L; Rorke LB; Davis RL; Hedley-Whyte TE
Cancer; 2000 Mar; 88(6):1477-83. PubMed ID: 10717633
[TBL] [Abstract][Full Text] [Related]
6. Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior.
McManamy CS; Pears J; Weston CL; Hanzely Z; Ironside JW; Taylor RE; Grundy RG; Clifford SC; Ellison DW;
Brain Pathol; 2007 Apr; 17(2):151-64. PubMed ID: 17388946
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.
Eberhart CG; Kepner JL; Goldthwaite PT; Kun LE; Duffner PK; Friedman HS; Strother DR; Burger PC
Cancer; 2002 Jan; 94(2):552-60. PubMed ID: 11900240
[TBL] [Abstract][Full Text] [Related]
8. Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review.
Triscott J; Yip S; Johnston D; Michaud J; Rassekh SR; Hukin J; Dunn S; Dunham C
Pediatr Dev Pathol; 2021; 24(4):309-317. PubMed ID: 33749384
[TBL] [Abstract][Full Text] [Related]
9. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
[TBL] [Abstract][Full Text] [Related]
10. Medulloblastoma: presentation, diagnosis and management.
Packer RJ; Finlay JL
Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
[TBL] [Abstract][Full Text] [Related]
11. Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline.
Pietsch T; Haberler C
Clin Neuropathol; 2016; 35(6):344-352. PubMed ID: 27781424
[TBL] [Abstract][Full Text] [Related]
12. Classification of childhood medulloblastoma into WHO-defined multiple subtypes based on textural analysis.
Das D; Mahanta LB; Ahmed S; Baishya BK
J Microsc; 2020 Jul; 279(1):26-38. PubMed ID: 32271463
[TBL] [Abstract][Full Text] [Related]
13. Prognostic limitations of the Daumas-Duport grading scheme in infratentorial neuroglial tumors in children.
Gilles FH; Tavaré CJ; Leviton A; Hedley-Whyte ET; Sotrel A; Adelman L; Davis RL; Rorke LB;
Pediatr Dev Pathol; 2004; 7(2):138-47. PubMed ID: 14994132
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma: what is the role of molecular genetics?
Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
[TBL] [Abstract][Full Text] [Related]
15. Stratification of medulloblastoma on the basis of histopathological grading.
Giangaspero F; Wellek S; Masuoka J; Gessi M; Kleihues P; Ohgaki H
Acta Neuropathol; 2006 Jul; 112(1):5-12. PubMed ID: 16685513
[TBL] [Abstract][Full Text] [Related]
16. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar neurocytoma in an infant: an important differential diagnosis from cerebellar neuroblastoma and medulloblastoma?
Brandis A; Heyer R; Hori A; Walter GF
Neuropediatrics; 1997 Aug; 28(4):235-8. PubMed ID: 9309715
[TBL] [Abstract][Full Text] [Related]
18. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.
Amlashi SF; Riffaud L; Brassier G; Morandi X
Cancer; 2003 Aug; 98(3):618-24. PubMed ID: 12879481
[TBL] [Abstract][Full Text] [Related]
19. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
[TBL] [Abstract][Full Text] [Related]
20. [Cerebellar medulloblastoma in a 65-year old patient].
Kroh H; Kostkiewicz B
Neurol Neurochir Pol; 1993; 27(5):757-65. PubMed ID: 8115001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
